Skip to content
← All startups
SeqOne logo

SeqOne

Series A

Provider of bioinformatics tools for the analysis of genome sequencing data. The platform helps researchers to detect & identify the variants responsible for gene mutation. It helps to detect many types of variants such as SNPs, Indels, CNVs, and mid-sized deletions. Founded in 2017, headquartered in Montpellier, France. The company has raised $48.8M in funding at the series a stage. The team comprises 113 (Jun 30,…

HealthTech · Life Sciences Tech, · Montpellier, France · EST 2017

About

Provider of bioinformatics tools for the analysis of genome sequencing data. The platform helps researchers to detect & identify the variants responsible for gene mutation. It helps to detect many types of variants such as SNPs, Indels, CNVs, and mid-sized deletions. Founded in 2017, headquartered in Montpellier, France. The company has raised $48.8M in funding at the series a stage. The team comprises 113 (Jun 30, 2026) employees. SeqOne operates in the Life Sciences Tech, Life Sciences Platforms and Tools, Genomics sectors. The company focuses on Sequencing Analysis, Integrative Bioinformatics Platforms, Life Sciences Platforms and Tools. Notable investors include Elaia, IRDI Soridec Gestion, Bpifrance, Omnes Capital, Merieux Equity Partners, Software Club, among others. The company has a team of 113 employees.

Business model

Life Sciences Tech > Research & Development > Drug Discovery > Genomics > Sequencing Analysis,

Genomics > Genome Informatics > Integrative Bioinformatics Platforms,

Life Sciences Platforms and Tools > Research Services > Genomics > Next Generation Sequencing (NGS)

Institutional investors

ElaiaIRDI Soridec GestionBpifranceOmnes CapitalMerieux Equity PartnersSoftware ClubIRDI Capital InvestissementSupernova InvestKorys

Latest coverage

📰 See all funding news — keep up with the raises that set comps.

Backed by funds in our directory

🗂️ Explore HealthTech investors — funds that write checks in this sector.

Raising like SeqOne?

Analyze your pitch deck before your next raise.

Analyze My Deck →